Skip to content
Home / Companies / GNLX GNL
GENELUX Corp (GNLX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest GNLX Insider Trades
About GENELUX Corp (GNLX) Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Headquarters WESTLAKE VILLAGE, CA
Employees 26
Listed 2023
Exchange XNAS https://www.genelux.com SEC filings for GNLX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 6 26,521 $78K Grant or award 13 1,777,523
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
GNLX Insider Transactions (Form 4) 62 66 Form 4 filings on record, the earliest from Oct 21, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Sep 1, 2025 JC Joseph Cappello - Officer Derivative Stock Option (Right to Buy)
Recent GNLX Form 8-K Filings 2
Recent GNLX Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jul 1, 2026 - - - - View on EDGAR Jun 1, 2026 - - -
GNLX Insider Trading - FAQ
What is the latest insider trade for GNLX? GENELUX Corp (GNLX) had 15 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for GNLX runs to 66 Form 4 filings, the earliest from 2024-10-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying GNLX stock? No insider purchases of GNLX were filed in the last 90 days.
How many insiders are selling GNLX stock? 6 insider sales of GNLX were filed in the last 90 days, totaling $78K.
Where can I see GNLX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks GNLX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow GNLX insider buys? Create a free InsiderAlpha account and press Watch on this page to add GNLX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track GNLX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Open-market sale
$2K
JT John Thomas - Director Open-market sale $30K
Jun 1, 2026
YY Yong Yu - Officer Open-market sale $2K
May 11, 2026
Market cap $120.35M
P/E ratio -
Dividend yield -
Average volume 242.8K
52 week high $8.54
52 week low $2.29
Today's high -
Today's low -
Open -
Volume -
Previous close $2.66
Shares outstanding 45.25M Market cap
$120.35M
26 employees
GNLX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 6 sales totaling $78K.
Most-Active GNLX Insiders - Last 90 Days 10 Sep 1, 2025 JC Joseph Cappello - Officer Grant or award Stock Option (Right to Buy) 16,666 - -
Sep 1, 2025 JC Joseph Cappello - Officer Derivative Stock Option (Right to Buy) 80,000 - -
Sep 1, 2025 JC Joseph Cappello - Officer Grant or award Stock Option (Right to Buy) 80,000 - -
Sep 1, 2025 JC Joseph Cappello - Officer Derivative Stock Option (Right to Buy) 13,333 - -
Sep 1, 2025 JC Joseph Cappello - Officer Grant or award Stock Option (Right to Buy) 13,333 - -
Sep 1, 2025 JC Joseph Cappello - Officer Derivative Stock Option (Right to Buy) 65,000 - -
Sep 1, 2025 JC Joseph Cappello - Officer Grant or award Stock Option (Right to Buy) 65,000 - -
Sep 1, 2025 RS Ralph Smalling - Officer Grant or award Common Stock 10,000 $0.00 -
Sep 1, 2025 RS Ralph Smalling - Officer Derivative Stock Option (Right to Buy) 8,333 - -
Sep 1, 2025 RS Ralph Smalling - Officer Grant or award Stock Option (Right to Buy) 8,333 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Derivative Stock Option (Right to Buy) 925,000 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Grant or award Stock Option (Right to Buy) 925,000 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Derivative Stock Option (Right to Buy) 157,372 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Grant or award Stock Option (Right to Buy) 157,372 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Derivative Stock Option (Right to Buy) 23,568 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Grant or award Stock Option (Right to Buy) 23,568 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Derivative Stock Option (Right to Buy) 250,000 - -
Sep 1, 2025 TZ Thomas Zindrick - Officer Grant or award Stock Option (Right to Buy) 250,000 - -
Sep 1, 2025 YY Yong Yu - Officer Derivative Stock Option (Right to Buy) 207,652 - -
Sep 1, 2025 YY Yong Yu - Officer Grant or award Stock Option (Right to Buy) 207,652 - -
Sep 1, 2025 YY Yong Yu - Officer Derivative Stock Option (Right to Buy) 65,000 - -
Sep 1, 2025 YY Yong Yu - Officer Grant or award Stock Option (Right to Buy) 65,000 - -
Aug 27, 2025 MM Mary Mirabelli - Director Grant or award Common Stock 22,283 $0.00 -
Aug 27, 2025 MM Mary Mirabelli - Director Grant or award Stock Option (Right to Buy) 28,576 $0.00 -
Aug 27, 2025 JT John Thomas - Director Grant or award Common Stock 22,283 $0.00 -
Aug 27, 2025 JT John Thomas - Director Grant or award Stock Option (Right to Buy) 28,576 $0.00 -
Aug 27, 2025 JC Joseph Cappello - Officer Grant or award Common Stock 107,500 $0.00 -
Aug 27, 2025 JC Joseph Cappello - Officer Grant or award Stock Option (Right to Buy) 142,500 $0.00 -
Aug 27, 2025 RS Ralph Smalling - Officer Grant or award Common Stock 26,230 $0.00 -
Aug 27, 2025 RS Ralph Smalling - Officer Grant or award Stock Option (Right to Buy) 34,770 $0.00 -
Aug 27, 2025 TZ Thomas Zindrick - Officer Grant or award Common Stock 361,200 $0.00 -
Aug 27, 2025 TZ Thomas Zindrick - Officer Grant or award Stock Option (Right to Buy) 478,800 $0.00 -
Aug 27, 2025 JS John W. Smither - Director Grant or award Common Stock 22,283 $0.00 -
Aug 27, 2025 JS John W. Smither - Director Grant or award Stock Option (Right to Buy) 28,576 $0.00 -
Aug 27, 2025 JT James L. Tyree - Director Grant or award Common Stock 22,283 $0.00 -
Aug 27, 2025 JT James L. Tyree - Director Grant or award Stock Option (Right to Buy) 28,576 $0.00 -
Aug 27, 2025 YY Yong Yu - Officer Grant or award Common Stock 101,480 $0.00 -
Aug 27, 2025 YY Yong Yu - Officer Grant or award Stock Option (Right to Buy) 134,520 $0.00 -
Jul 1, 2025 EG Eric Groen - Officer Grant or award Stock Option (Right to Buy) 270,000 $0.00 -
May 12, 2025 JC Joseph Cappello - Officer Open-market sale Common Stock 4,737 $2.92 $14K
May 12, 2025 YY Yong Yu - Officer Open-market sale Common Stock 5,579 $2.92 $16K
May 12, 2025 RS Ralph Smalling - Officer Open-market sale Common Stock 1,259 $2.92 $4K
May 12, 2025 SR Sean Ryder - Officer Open-market sale Common Stock 4,475 $2.92 $13K
May 12, 2025 TZ Thomas Zindrick - Officer Open-market sale Common Stock 10,764 $2.92 $31K
Mar 14, 2025 YY Yong Yu - Officer Grant or award Common Stock 13,350 $0.00 -
Mar 14, 2025 SR Sean Ryder - Officer Grant or award Common Stock 10,708 $0.00 -
Mar 14, 2025 RS Ralph Smalling - Officer Grant or award Common Stock 4,172 $0.00 -
Mar 14, 2025 JC Joseph Cappello - Officer Grant or award Common Stock 13,350 $0.00 -
Mar 14, 2025 TZ Thomas Zindrick - Officer Grant or award Common Stock 30,339 $0.00 -
Dec 18, 2024 SR Sean Ryder - Officer Grant or award Common Stock 22,000 $0.00 -
Dec 18, 2024 SR Sean Ryder - Officer Grant or award Stock Option (right to buy) 30,000 $0.00 -
Dec 18, 2024 TZ Thomas Zindrick - Officer Grant or award Common Stock 134,500 $0.00 -
Dec 18, 2024 TZ Thomas Zindrick - Officer Grant or award Stock Option (right to buy) 183,000 $0.00 -
Dec 18, 2024 YY Yong Yu - Officer Grant or award Common Stock 29,000 $0.00 -
Dec 18, 2024 YY Yong Yu - Officer Grant or award Stock Option (right to buy) 39,000 $0.00 -
Dec 18, 2024 RS Ralph Smalling - Officer Grant or award Common Stock 15,525 $0.00 -
Dec 18, 2024 RS Ralph Smalling - Officer Grant or award Stock Option (right to buy) 21,100 $0.00 -
Dec 18, 2024 LZ Lourie S. Zak - Officer Grant or award Common Stock 41,650 $0.00 -
Dec 18, 2024 LZ Lourie S. Zak - Officer Grant or award Stock Option (right to buy) 56,525 $0.00 -
$GRML
Greenland Mines Ltd
$IONS
IONIS PHARMACEUTICALS INC
Joseph Cappello - Officer
